Exhibit 107

Calculation of Filing Fee Table

Form S-1

(Form Type)

Inhibikase Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security

Type

  

Security

Class

Title

  

Fee

Calculation

or Carry

Forward

Rule

  

Amount

Registered

  

Proposed

Maximum

Offering

Price Per
Unit

  

Maximum

Aggregate

Offering

Price (1)(2)

  

Fee

Rate

  

Amount of

Registration
Fee

                 
Fees to be paid   Equity   Common Stock   457(o)       $13,000,000(3)   0.00014760    $1,918.80
                 
    Equity   Pre-funded warrants   457(g)       $ (4)     $
                 
    Equity   Common Warrants   457(g)       $— (4)   —   $—
                 
    Equity   Placement Agent Warrants   457(g)       $— (4)   —   $—
                 
    Equity   Common Stock Underlying Pre-Funded Warrants   457(o)       $— (3)   —   $—
                 
    Equity   Common Stock Underlying Common Warrants   457(o)       $13,000,000   0.00014760   $1,918.80
                 
    Equity   Common Stock Underlying Placement Agent Warrants   457(o)       $910,000   0.00014760   $134.32
           
      Total Offering Amounts   $26,910,000     $3,971.92
           
      Total Fees Previously Paid       $—
           
      Total Fee Offsets       $—
           
        Net Fee Due           $3,971.92

 

(1)

Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended, or the Securities Act.

(2)

Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(3)

The proposed maximum aggregate offering price of the common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants sold in the offering, and, as such, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $13,000,000.

(4)

Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants.